News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

about

Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

P2860

Q58695482-C9598404-94A1-47C7-8708-BD793D4E9932

P2860

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

Item

http://www.wikidata.org/entity/Q39446111

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@en

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@nl

type

Item

label

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@en

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@nl

prefLabel

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@en

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@nl

P1476

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

@en

P2093

Hermine Agis

http://www.w3.org/2001/XMLSchema#string

P2860

Update on treatment of light chain amyloidosis

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

Amyloidosis-where are we now and where are we heading?

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

Molecular mechanisms of amyloidosis.

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.

P2888

s12254-017-0332-6

P304

66-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12254-017-0332-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28725274

http://www.w3.org/2001/XMLSchema#string

P932

5493729

http://www.w3.org/2001/XMLSchema#string

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

about

P2860

P2860

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932